18F-radiopharmacokinetics of [18F]-5-fluorouracil in a mouse bearing two Colon tumors with a different 5-fluorouracil sensitivity: A study for a correlation with oncological results
- 1 April 1996
- journal article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 23 (3) , 333-342
- https://doi.org/10.1016/0969-8051(95)02088-8
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Predictive value of thymidylate synthase and dihydropyrimidine dehydrogenaseEuropean Journal Of Cancer, 1994
- Association of intratumoral pharmacokinetics of fluorouracil with clinical responseThe Lancet, 1994
- Tumour pharmacokinetics?—we do need to knowThe Lancet, 1994
- Severe Fluorouracil Toxicity in a Patient With Dihydropyrimidine Dehydrogenase DeficiencyJNCI Journal of the National Cancer Institute, 1993
- Prolonged retention of high concentrations of 5-fluorouracil in human and murine tumors as compared with plasmaCancer Chemotherapy and Pharmacology, 1993
- Novel approaches to selective treatments of human solid tumors: Laboratory and clinical correlationAnnals of Oncology, 1993
- Clinical relevance of biochemical modulation of 5-fluorouracilAnnals of Oncology, 1991
- Prediction of 5-fluorouracil cytotoxicity towards the Walker carcinosarcoma using peak integrals of fluoronucleotides measured by MRS in vivoBritish Journal of Cancer, 1989
- Clinical Pharmacology of 5-FluorouracilClinical Pharmacokinetics, 1989
- Fluorouracil: biochemistry and pharmacology.Journal of Clinical Oncology, 1988